Skip to content
10-Q

Quarterly Report

cbdMD, Inc. YCBD

0001437749-26-017042

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · May 13, 2026 10.5M sh
Capex Q2 2026 · Mar 31, 2026 $170.55K
Capex Q2 2026 · Mar 31, 2025 $179.89K
Operating Cash Flow Q2 2026 · Mar 31, 2026 −$1.53M
Operating Cash Flow Q2 2026 · Mar 31, 2025 −$507.43K
Cash And Equivalents Q2 2026 · Mar 31, 2026 $2.64M
Cash And Equivalents Q2 2026 · Sep 30, 2025 $2.26M
Stockholders Equity Q2 2026 · Mar 31, 2026 $9.28M
Stockholders Equity Q2 2026 · Sep 30, 2025 $7.23M
Stockholders Equity Q2 2026 · Mar 31, 2025 $665.8K
Stockholders Equity Q2 2026 · Sep 30, 2024 $1.96M
Current Liabilities Q2 2026 · Mar 31, 2026 $2.97M
Current Liabilities Q2 2026 · Sep 30, 2025 $3.19M
Total Liabilities Q2 2026 · Mar 31, 2026 $2.97M
Total Liabilities Q2 2026 · Sep 30, 2025 $3.19M
Current Assets Q2 2026 · Mar 31, 2026 $8.38M
Current Assets Q2 2026 · Sep 30, 2025 $6.55M
Total Assets Q2 2026 · Mar 31, 2026 $12.25M
Total Assets Q2 2026 · Sep 30, 2025 $10.42M
Eps Basic Q2 2026 · Mar 31, 2026 −$0.08
Eps Basic Q2 2026 · Mar 31, 2026 −$0.12
Eps Basic Q2 2026 · Mar 31, 2025 −$1.90
Eps Basic Q2 2026 · Mar 31, 2025 −$3.67
Net Income Q2 2026 · Mar 31, 2026 −$797.98K
Net Income Q2 2026 · Mar 31, 2026 −$1.08M
Net Income Q2 2026 · Mar 31, 2025 −$480.76K
Net Income Q2 2026 · Mar 31, 2025 −$465.66K
Operating Income Q2 2026 · Mar 31, 2026 −$800.78K
Operating Income Q2 2026 · Mar 31, 2026 −$1.09M
Operating Income Q2 2026 · Mar 31, 2025 −$485.82K
Operating Income Q2 2026 · Mar 31, 2025 −$572.09K
Gross Profit Q2 2026 · Mar 31, 2026 $3.26M
Gross Profit Q2 2026 · Mar 31, 2026 $6.26M
Gross Profit Q2 2026 · Mar 31, 2025 $2.96M
Gross Profit Q2 2026 · Mar 31, 2025 $6.36M
Cost Of Revenue Q2 2026 · Mar 31, 2026 $2.38M
Cost Of Revenue Q2 2026 · Mar 31, 2026 $4.4M
Cost Of Revenue Q2 2026 · Mar 31, 2025 $1.79M
Cost Of Revenue Q2 2026 · Mar 31, 2025 $3.5M
Revenue Q2 2026 · Mar 31, 2026 $5.64M
Revenue Q2 2026 · Mar 31, 2026 $10.66M
Revenue Q2 2026 · Mar 31, 2025 $4.75M
Revenue Q2 2026 · Mar 31, 2025 $9.86M